Specialist cancer hospital The Christie’s consultancy arm Christie International has announced its first major overseas partnership.

Cork University Hospital (CUH) in the Republic of Ireland plans to build a new state-of-the-art radiation oncology centre and The Christie International team, which co-ordinates consultancy advice to overseas healthcare providers across a range of areas, is supporting CUH in its plans.

The €40 million (£35.5m) development will mean CUH will be able to deliver a wide range of world class treatment options.

The initial phase of work has seen experts primarily from The Christie’s radiotherapy and medical physics teams attend and organise reciprocal visits with their counterparts in Cork.

The new centre is scheduled to be completed in January 2019, with the first patient treatment scheduled for April 2019.

The Christie’s Chief Executive Roger Spencer, said: “We are delighted to be working with Cork University Hospital and to support its ambition to become the leading centre of oncology excellence in Ireland. We look forward to continuing our partnership with CUH as it moves towards establishing what it wants to become a world-class centre.”

Speaking at the launch event in Cork, the chairwoman of the South/South West Hospital Group, Professor Geraldine McCarthy, said the partnership with The Christie was of major significance and would deliver great benefits to the public.

She added: “This new radiation oncology centre will enable CUH to provide a range of much needed cancer treatment services and will lead to improved patient waiting times for critical services.”

And Professor Nick Slevin, consultant clinical oncologist, and The Christie’s associate medical director, added: “We continue to work closely with the excellent multidisciplinary team at CUH. We are supporting it in its implementation of state-of-the-art radiotherapy techniques which will provide the best possible outcomes for its patients”

The new radiation oncology centre at CUH is a part of the National Plan for Radiation Oncology (NPRO), a plan by the Irish government to develop a national network of radiation oncology services. 

As well as offering consultancy advice overseas, The Christie also promotes training and education available to international students, through The School of Oncology and The University of Manchester.

The Christie NHS Foundation Trust has been ranked ‘Outstanding’ by the health regulator the Care Quality Commission (CQC) which referred to it as ‘exceptional’ and ‘a leader in its field’. It not only commended the Trust for its effectiveness and care, but highlighted its work in shaping the future of cancer care and noted the reach and influence of its clinical research projects. The CQC also rated The Christie the best specialist trust in the country, and one of the top three trusts overall in England.